M. Bossens

747 total citations
25 papers, 510 citations indexed

About

M. Bossens is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, M. Bossens has authored 25 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Oncology and 5 papers in Surgery. Recurrent topics in M. Bossens's work include Cervical Cancer and HPV Research (10 papers), Parvovirus B19 Infection Studies (4 papers) and Herpesvirus Infections and Treatments (4 papers). M. Bossens is often cited by papers focused on Cervical Cancer and HPV Research (10 papers), Parvovirus B19 Infection Studies (4 papers) and Herpesvirus Infections and Treatments (4 papers). M. Bossens collaborates with scholars based in Belgium, Netherlands and Bolivia. M. Bossens's co-authors include Robert Snoeck, Erik De Clercq, Jean‐Christophe Noël, Dominique Parent, Christine Müller, L Thiry, S. Sprecher-Goldberger, Charles H. Kirkpatrick, Howard S. Jaffe and B. Delaere and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

M. Bossens

22 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Bossens Belgium 12 303 108 108 85 73 25 510
Elopy Sibanda Zimbabwe 14 214 0.7× 83 0.8× 68 0.6× 101 1.2× 110 1.5× 55 677
Irma Ikäheimo Finland 15 192 0.6× 124 1.1× 42 0.4× 144 1.7× 183 2.5× 34 691
Wendy C. S. Ho Hong Kong 15 361 1.2× 149 1.4× 59 0.5× 123 1.4× 28 0.4× 37 573
Somchai Niruthisard Thailand 14 349 1.2× 105 1.0× 82 0.8× 161 1.9× 54 0.7× 35 748
Christian C. Patrick United States 13 230 0.8× 71 0.7× 110 1.0× 94 1.1× 42 0.6× 32 604
Krisztina Szarka Hungary 16 390 1.3× 150 1.4× 177 1.6× 174 2.0× 47 0.6× 50 756
Tatsuru Yamanaka Japan 12 675 2.2× 61 0.6× 56 0.5× 27 0.3× 107 1.5× 37 963
Sandhia Naik United Kingdom 13 617 2.0× 155 1.4× 62 0.6× 95 1.1× 194 2.7× 31 1.1k
H Birley United Kingdom 10 466 1.5× 162 1.5× 47 0.4× 53 0.6× 232 3.2× 24 799
Josef Yeager United States 16 382 1.3× 78 0.7× 99 0.9× 32 0.4× 55 0.8× 36 756

Countries citing papers authored by M. Bossens

Since Specialization
Citations

This map shows the geographic impact of M. Bossens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bossens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bossens more than expected).

Fields of papers citing papers by M. Bossens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bossens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bossens. The network helps show where M. Bossens may publish in the future.

Co-authorship network of co-authors of M. Bossens

This figure shows the co-authorship network connecting the top 25 collaborators of M. Bossens. A scholar is included among the top collaborators of M. Bossens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Bossens. M. Bossens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bossens, M., et al.. (2020). Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia. BMC Infectious Diseases. 20(1). 259–259. 4 indexed citations
2.
Alexander, Sophie, et al.. (2019). Evaluation of the self-sampling for cervical cancer screening in Bolivia. BMC Public Health. 19(1). 80–80. 25 indexed citations
3.
Delvigne, Annick, et al.. (2018). More women gynecologists in Belgium: assessment of changes in the workforce—a survey. Archives of Gynecology and Obstetrics. 298(6). 1139–1148.
4.
Bossens, M., Maud Jost, Viviane De Maertelaer, et al.. (2018). Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation. International Journal of Clinical Pharmacology and Therapeutics. 56(3). 134–141. 3 indexed citations
5.
Weyn, Christine, Daniel Thomas, Jacques Jani, et al.. (2010). Evidence of Human Papillomavirus in the Placenta. The Journal of Infectious Diseases. 203(3). 341–343. 46 indexed citations
6.
Rozenberg, Serge, Yannick Manigart, Christine Gilles, et al.. (2009). Topical treatment of CIN 2+ by cidofovir: Results of a phase II, double-blind, prospective, placebo-controlled study. Gynecologic Oncology. 115(1). 69–74. 49 indexed citations
7.
Bossens, M., et al.. (2003). National Survey on Cholecystectomy Related Bile Duct Injury - Public Health and Financial Aspects in Belgian Hospitals - 1997. Acta chirurgica Belgica. 103(2). 168–180. 23 indexed citations
8.
Goossens, Herman, et al.. (2001). ['Evidence-based' perioperative antibiotic prophylaxis policy in Belgian hospitals after a change in the reimbursement system].. PubMed. 145(37). 1773–7. 8 indexed citations
9.
Verschraegen, Claire F., M. Bossens, Andrzej P. Kudelka, et al.. (2001). Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir. Journal of Medical Virology. 64(2). 195–198. 24 indexed citations
10.
Snoeck, Robert, M. Bossens, Dominique Parent, et al.. (2001). Phase II Double‐Blind, Placebo‐Controlled Study of the Safety and Efficacy of Cidofovir Topical Gel for the Treatment of Patients with Human Papillomavirus Infection. Clinical Infectious Diseases. 33(5). 597–602. 90 indexed citations
11.
Snoeck, Robert, Jean‐Christophe Noël, Christine Müller, Erik De Clercq, & M. Bossens. (2000). Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III). Journal of Medical Virology. 60(2). 205–209. 68 indexed citations
12.
Snoeck, Robert, et al.. (1997). Preliminary results on the activity of cidofovir for the treatment of cervical intraepithelial neoplasia (CIN) grade III. Antiviral Research. 34(2). A72–A72. 1 indexed citations
13.
Bossens, M., Jan P. van Straalen, T.M. De Reijke, K. H. Kurth, & Gerard T. Sanders. (1995). Kinetics of prostate-specific antigen after manipulation of the prostate. European Journal of Cancer. 31(5). 682–685. 12 indexed citations
14.
Straalen, Jan P. van, M. Bossens, T.M. De Reijke, & Gerard T. Sanders. (1994). Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy. Clinical Chemistry and Laboratory Medicine (CCLM). 32(2). 53–56. 17 indexed citations
15.
16.
Petit, P., M. Bossens, Debby Thomas, et al.. (1987). Type III congenital cystic adenomatoid malformation of the lung: another cause of elevated alpha fetoprotein?. Clinical Genetics. 32(3). 172–174. 6 indexed citations
17.
Thiry, L, S. Sprecher-Goldberger, J. Cogniaux-Leclerc, R. Cappel, & M. Bossens. (1979). Comparison of different tests to measure immune responses to primate retroviruses. Journal of Immunological Methods. 25(3). 197–209. 4 indexed citations
18.
Thiry, L, et al.. (1978). Neutralization of Mason-Pfizer Virus by Sera from Patients Treated for Renal Disease. Journal of General Virology. 41(3). 587–597. 10 indexed citations
19.
Thiry, L, et al.. (1978). Cell-Mediated Immune Response to Simian Oncornavirus Antigens in Pregnant Women 2. JNCI Journal of the National Cancer Institute. 60(3). 527–532. 21 indexed citations
20.
Thiry, L, et al.. (1977). Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma.. PubMed. 37(5). 1301–6. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026